Soticlestat
takeda
['takeda']
long-term safety &amp; efficacy findings from soticlestat open label extension study presented by takeda at american academy of neurology annual meeting $ovid 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2